Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Gavilimomab> ?p ?o. }
Showing items 1 to 48 of
48
with 100 items per page.
- Gavilimomab abstract "Gavilimomab (also known as ABX-CBL) is a mouse monoclonal antibody intended for use as an immunosuppressive biologic treatment of glucocorticoid-resistant graft versus host disease. It binds to the antigen CD147. Gavilimomab proved slightly less effective than standard antithymocyte globulin therapy.It was originally developed by Abgenix, which was later acquired by Amgen.".
- Gavilimomab atcPrefix "none".
- Gavilimomab casNumber "244096-20-6".
- Gavilimomab wikiPageID "9041996".
- Gavilimomab wikiPageRevisionID "600987418".
- Gavilimomab atcPrefix "none".
- Gavilimomab casNumber "244096".
- Gavilimomab chemspiderid "NA".
- Gavilimomab hasPhotoCollection Gavilimomab.
- Gavilimomab mabType "mab".
- Gavilimomab source "o".
- Gavilimomab target Basigin.
- Gavilimomab type "mab".
- Gavilimomab verifiedfields "changed".
- Gavilimomab verifiedrevid "458275362".
- Gavilimomab subject Category:Monoclonal_antibodies_for_tumors.
- Gavilimomab type Abstraction100002137.
- Gavilimomab type Antibody115027189.
- Gavilimomab type Chemical114806838.
- Gavilimomab type Compound114818238.
- Gavilimomab type Macromolecule114944888.
- Gavilimomab type Material114580897.
- Gavilimomab type Matter100020827.
- Gavilimomab type Molecule114682133.
- Gavilimomab type MonoclonalAntibodiesForTumors.
- Gavilimomab type MonoclonalAntibody115029781.
- Gavilimomab type OrganicCompound114727670.
- Gavilimomab type Part113809207.
- Gavilimomab type PhysicalEntity100001930.
- Gavilimomab type Protein114728724.
- Gavilimomab type Relation100031921.
- Gavilimomab type Substance100019613.
- Gavilimomab type Thing100002452.
- Gavilimomab type Unit109465459.
- Gavilimomab type Drug.
- Gavilimomab type DrugProduct.
- Gavilimomab type FunctionalSubstance.
- Gavilimomab comment "Gavilimomab (also known as ABX-CBL) is a mouse monoclonal antibody intended for use as an immunosuppressive biologic treatment of glucocorticoid-resistant graft versus host disease. It binds to the antigen CD147. Gavilimomab proved slightly less effective than standard antithymocyte globulin therapy.It was originally developed by Abgenix, which was later acquired by Amgen.".
- Gavilimomab label "Gavilimomab".
- Gavilimomab label "Gavilimomab".
- Gavilimomab label "غافيليموماب".
- Gavilimomab sameAs Gavilimomab.
- Gavilimomab sameAs m.027vm84.
- Gavilimomab sameAs Q3758982.
- Gavilimomab sameAs Q3758982.
- Gavilimomab sameAs Gavilimomab.
- Gavilimomab wasDerivedFrom Gavilimomab?oldid=600987418.
- Gavilimomab isPrimaryTopicOf Gavilimomab.